HTDS

Hard to Treat Diseases Inc. HTDS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HTDS AMBS AMPE GSTC IRBS MOBO ARMM GBLX GREH MBGNF
6M 100.00 % -40.00 % 3 885.71 % -50.00 % 0.00 % 0.00 % 0.00 % 0.00 % -90.40 % -41.00 %
YTD 1 900.00 % 200.00 % 3 119.23 % -75.00 % 0.00 % 0.00 % 0.00 % -95.56 % -90.40 % -41.00 %
1Y 100.00 % 200.00 % 3 704.55 % -75.00 % 0.00 % -96.55 % 0.00 % -96.67 % -95.20 % -41.00 %
3Y 100.00 % -88.89 % -99.07 % -96.30 % 5 900.00 % -98.89 % -99.92 % -99.27 % -97.60 % -94.42 %
5Y -80.00 % -95.71 % -99.97 % -98.59 % 5 900.00 % -99.52 % -99.98 % -99.29 % -99.87 % -88.18 %
10Y -80.00 % -99.97 % -99.89 % -99.99 % 5 900.00 % -99.87 % -99.98 % -99.95 % -52.00 % -88.97 %
From the beginning -100.00 % 421 840.93 % -99.90 % -99.96 % 5 900.00 % -99.97 % -99.98 % -100.00 % -100.00 % -88.97 %

Dividend